Cinzia Fionda

Pubblicazioni

Titolo Pubblicato in Anno
Hitting More Birds with a Stone: Impact of TGF-β on ILC Activity in Cancer JOURNAL OF CLINICAL MEDICINE 2020
CD155: a multi-functional molecule in tumor progression INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2020
Bone marrow stromal cell-derived IL-8 upregulates PVR expression on multiple myeloma cells via NF-kB transcription factor CANCERS 2020
Multicentre harmonisation of a six-colour flow cytometry panel for naïve/memory T cell immunomonitoring JOURNAL OF IMMUNOLOGY RESEARCH 2020
Negative regulation of innate lymphoid cell responses in inflammation and cancer IMMUNOLOGY LETTERS 2019
The Ubiquitin-proteasome pathway regulates Nectin2/CD112 expression and impairs NK cell recognition and killing. EUROPEAN JOURNAL OF IMMUNOLOGY 2019
The homeobox transcription factor MEIS2 is a regulator of cancer cell survival and IMiDs activity in multiple myeloma. modulation by bromodomain and Extra-Terminal (BET) protein inhibitors CELL DEATH & DISEASE 2019
Activation of liver X receptor up-regulates the expression of the NKG2D ligands MICA and MICB in multiple myeloma through different molecular mechanisms THE FASEB JOURNAL 2019
The POU-Domain Transcription Factor Oct-6/POU3F1 as a Regulator of Cellular Response to Genotoxic Stress CANCERS 2019
NK cell reconstitution in paediatric leukemic patients after T-cell-depleted HLA-haploidentical haematopoietic stem cell transplantation followed by the reinfusion of iCasp9-modified donor T cells JOURNAL OF CLINICAL MEDICINE 2019
NKG2D and its ligands: one for all, all for one FRONTIERS IN IMMUNOLOGY 2018
Impact of bone marrow-derived signals on NK cell development and functional maturation CYTOKINE & GROWTH FACTOR REVIEWS 2018
Drug-induced senescent Multiple Myeloma cells elicit NK cell proliferation by direct or exosome-mediated IL-15 trans-presentation CANCER IMMUNOLOGY RESEARCH 2018
MICA-129 dimorphism and soluble MICA are associated with the progression of multiple myeloma FRONTIERS IN IMMUNOLOGY 2018
Translating the anti-myeloma activity of Natural Killer cells into clinical application CANCER TREATMENT REVIEWS 2018
JAK/STAT signaling in regulation of innate lymphoid cells: The gods before the guardians IMMUNOLOGICAL REVIEWS 2018
Key role of the CD56lowCD16low Natural Killer cell subset in the recognition and killing of Multiple Myeloma cells CANCERS 2018
p38 MAPK differentially controls NK activating ligands at transcriptional and post-transcriptional level on multiple myeloma cells ONCOIMMUNOLOGY 2017
Genotoxic stress modulates the release of exosomes from multiple myeloma cells capable of activating NK cell cytokine production: role of HSP70/TLR2/NF-kB axis ONCOIMMUNOLOGY 2017
Role of distinct natural killer cell subsets in anticancer response FRONTIERS IN IMMUNOLOGY 2017

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma